S&P 500 Healthcare Sector SEC Filings — October 23, 2026

Executive Summary

This digest covers a single Form 4-type insider transaction filing from Elevance Health, Inc. (an S&P 500 managed care/healthcare provider within scope). The only enriched event is a series of sales by EVP & CFO Kaye Mark totaling 2,343 shares at roughly $441 (~$1.03M), with 13 transactions reported and 19,919 shares retained afterward.

Executed prices clustered between $434 and $441, with individual lots of 400, 321 and 1,660 shares. No period-over-period financial comparisons, guidance, capital allocation changes, M&A, or scheduled events were supplied in the enriched data, so portfolio-level trend analysis is not possible from this single filing. The filing's sentiment is classified negative with 7/10 materiality, which reflects the insider selling rather than any fundamental deterioration. Investors should treat this as a limited-information signal and look for the company's periodic financial filings and guidance to contextualize it.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Form 4

Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from October 22, 2026.